[Development of leukemia L-1210 after treatment with the methionine synthetase inhibitor quinoline dibromide].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D011806:Quinolinium Compounds / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011806:Quinolinium Compounds; D003561:Cytarabine; C018435:quinolinium dibromide
Razvitie leĭkoza L-1210 pri deĭstvii ingibitora metioninsintetazy khinolina dibromida.